AdvisorNet Financial Inc Sells 79 Shares of Zoetis Inc. (NYSE:ZTS)

AdvisorNet Financial Inc trimmed its holdings in Zoetis Inc. (NYSE:ZTSFree Report) by 5.6% in the fourth quarter, HoldingsChannel reports. The fund owned 1,335 shares of the company’s stock after selling 79 shares during the period. AdvisorNet Financial Inc’s holdings in Zoetis were worth $218,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. PFW Advisors LLC purchased a new stake in Zoetis during the fourth quarter valued at about $1,764,000. Peddock Capital Advisors LLC lifted its stake in shares of Zoetis by 1.4% in the 4th quarter. Peddock Capital Advisors LLC now owns 7,562 shares of the company’s stock valued at $1,232,000 after acquiring an additional 107 shares during the last quarter. Miracle Mile Advisors LLC purchased a new stake in Zoetis during the 4th quarter valued at about $272,000. Pallas Capital Advisors LLC grew its position in Zoetis by 18.5% during the 4th quarter. Pallas Capital Advisors LLC now owns 9,398 shares of the company’s stock worth $1,531,000 after acquiring an additional 1,464 shares during the last quarter. Finally, Fulcrum Capital LLC increased its stake in Zoetis by 3.2% in the 4th quarter. Fulcrum Capital LLC now owns 50,818 shares of the company’s stock worth $8,280,000 after purchasing an additional 1,575 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the subject of a number of analyst reports. Leerink Partners began coverage on Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective for the company. Stifel Nicolaus cut their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. UBS Group assumed coverage on shares of Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective for the company. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a hold rating, nine have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Zoetis currently has a consensus rating of “Buy” and a consensus price target of $211.89.

Get Our Latest Research Report on ZTS

Zoetis Stock Up 1.3 %

ZTS stock opened at $169.30 on Friday. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.53. The company has a market capitalization of $76.38 billion, a price-to-earnings ratio of 31.82, a price-to-earnings-growth ratio of 2.51 and a beta of 0.89. The business’s 50 day moving average price is $171.25 and its two-hundred day moving average price is $180.07. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69.

Zoetis (NYSE:ZTSGet Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.36 earnings per share. As a group, analysts forecast that Zoetis Inc. will post 5.91 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This is a boost from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 dividend on an annualized basis and a yield of 1.18%. The ex-dividend date is Tuesday, January 21st. Zoetis’s dividend payout ratio (DPR) is 32.52%.

About Zoetis

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Read More

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTSFree Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.